Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v5-EN
Language French English
Date Updated 2020-08-24 2020-05-04
Drug Identification Number 02454807 02454807
Brand name SANDOZ DICLOFENAC OPHTHA SANDOZ DICLOFENAC OPHTHA
Common or Proper name DICLO OPHTHA DICLO OPHTHA
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients DICLOFENAC SODIUM DICLOFENAC SODIUM
Strength(s) 0.1% 0.1%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ml 5ml
ATC code S01BC S01BC
ATC description ANTIINFLAMMATORY AGENTS ANTIINFLAMMATORY AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-16 2020-03-16
Estimated end date 2020-08-07 2020-07-10
Actual end date 2020-08-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments